Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016613
Filing Date
2023-05-12
Accepted
2023-05-12 15:41:41
Documents
41
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 344414
2 ex31-1.htm EX-31.1 11197
3 ex31-2.htm EX-31.2 11101
4 ex32-1.htm EX-32.1 5348
5 form10-q_001.jpg GRAPHIC 2916
  Complete submission text file 0001493152-23-016613.txt   1825653

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cqens-20230331.xsd EX-101.SCH 17172
7 XBRL CALCULATION FILE cqens-20230331_cal.xml EX-101.CAL 30041
8 XBRL DEFINITION FILE cqens-20230331_def.xml EX-101.DEF 38127
9 XBRL LABEL FILE cqens-20230331_lab.xml EX-101.LAB 150653
10 XBRL PRESENTATION FILE cqens-20230331_pre.xml EX-101.PRE 110495
35 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 128475
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 23915274
SIC: 2834 Pharmaceutical Preparations